DiaMedica to Present at the 25th Annual Piper Jaffray Healthcare
(firmenpresse) - MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 11/20/13 -- DiaMedica (TSX VENTURE: DMA), a clinical stage biopharmaceutical company, has been invited to present at the 25th Annual Piper Jaffray Healthcare Conference, which will be held in New York December 3-4, 2013. DiaMedica's Chairman and Chief Executive Officer, Rick Pauls, will be presenting on Tuesday, December 3, at 1:50 p.m. ET.
The goal of Piper Jaffray's 25th Annual Healthcare Conference is to bring together key industry executives, investors and Piper professionals to provide multiple perspectives, investigate critical trends and identify the leaders in the markets that are driving our economy. The conference will be held at The New York Palace - New York.
About DiaMedica
DiaMedica Inc. is a publicly traded (TSX VENTURE: DMA) clinical stage biopharmaceutical company focused on the discovery and development of novel therapies to treat diabetes and the complications associated with diabetes. DiaMedica's lead clinical stage compound, DM199, is a recombinant human protein that represents a novel approach to treating diabetes and associated complications. DiaMedica is also developing a novel monoclonal antibody, DM204 for the treatment of Type 2 diabetes, which is in preclinical development.
The Company is listed on the TSX Venture Exchange in Canada under the trading symbol 'DMA'.
FORWARD-LOOKING STATEMENTS
The statements made in this press release that are not historical facts contain forward-looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address DiaMedica's expectations, should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements reflect a current view of future events and are subject to certain risks and uncertainties as contained in the Corporation's filings with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. The Corporation undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.
Contacts:
Rick Pauls
Chairman & CEO
DiaMedica Inc.
763-710-4455
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.11.2013 - 09:10 Uhr
Sprache: Deutsch
News-ID 1285425
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MINNEAPOLIS, MINNESOTA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 222 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DiaMedica to Present at the 25th Annual Piper Jaffray Healthcare
"
steht unter der journalistisch-redaktionellen Verantwortung von
DiaMedica Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
